Artiva Biotherapeutics, Inc. (ARTV)
3.14
+0.07
(+2.28%)
USD |
NASDAQ |
Dec 11, 16:00
3.09
-0.05
(-1.59%)
After-Hours: 20:00
Artiva Biotherapeutics Shareholders Equity (Quarterly): 129.22M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ovid Therapeutics, Inc. | 44.70M |
| Kezar Life Sciences, Inc. | 82.98M |
| Olema Pharmaceuticals, Inc. | 307.49M |
| Disc Medicine, Inc. | 573.39M |
| NovaBay Pharmaceuticals, Inc. | 1.634M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 148.86M |
| Total Liabilities (Quarterly) | 19.64M |
| Debt to Equity Ratio | 0.0905 |
| Current Ratio | 11.65 |
| Net Debt Paydown Yield | 1.17% |